title: Case Study of Intrapartum Antibiotic Prophylaxis and Subsequent Postpartum Beta-Lactam Anaphylaxis.
abstract: Universal screening for maternal group B Streptococcus (GBS) in the prenatal period has led to administration of intrapartum antibiotic prophylaxis (IAP). Although IAP decreased the rate of early neonatal GBS disease, exposure of childbearing women to penicillin and other beta-lactam antibiotics has increased. Beta-lactam-induced anaphylaxis in the breastfeeding woman during the postpartum period illustrates risk factors for beta-lactam allergy and anaphylaxis. Treatment and nursing implications for this adverse reaction are suggested.
authors.forename: Mary Ann
authors.initials: MA
authors.lastname: Stark
authors.forename: Mary Frances
authors.initials: MF
authors.lastname: Ross
authors.forename: Wendy
authors.initials: W
authors.lastname: Kershner
authors.forename: Kimberly
authors.initials: K
authors.lastname: Searing
mesh_terms: D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000009:adverse effects*; D019072:Antibiotic Prophylaxis / Q000009:adverse effects* / Q000379:methods; D005260:Female; D006801:Humans; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011644:Puerperal Disorders / Q000139:chemically induced* / Q000628:therapy; D013290:Streptococcal Infections / Q000517:prevention & control
chemical_list: D000900:Anti-Bacterial Agents
keywords: anaphylaxis; beta-lactam allergy; intrapartum antibiotic prophylaxis; maternal group B Streptococcus